The human metastasis-associated gene (MTA1), a member of the nucleosome remodeling complex with histone deacetylase activity, is frequently overexpressed in biologically aggressive epithelial neoplasms. Here, we extend this observation to squamous carcinoma cells, which express high levels of MTA1 relative to normal or immortalized keratinocytes. To address functional aspects of MTA1 expression, we established variants of human immortalized keratinocytes (HaCaT cells) by expressing MTA1 cDNA in both the sense and antisense orientations. We demonstrate that (1) forced MTA1 expression enhances migration and invasion of immortalized keratinocytes; (2) MTA1 expression is necessary but not sucient for cell survival in the anchorage independent state; (3) MTA1 contributes to expression of the anti-apoptotic Bcl-2 family member Bcl-x L ; (4) MTA1 expression in immortalized keratinocytes depends, in part, on activation of the epidermal growth factor receptor (EGFR). These results establish that, in keratinocytes, MTA1 expression contributes to several aspects of the metastatic phenotype including survival in the anchorage independent state, migration, and invasion.
Introduction
The metastasis associated 1 (MTA1) protein (Toh et al., 1994 (Toh et al., , 1995 is representative of a protein family highly conserved through evolution, which also includes the metastasis associated 1-like protein (MTA1-L1) (Futamura et al., 1999) , MTA2 (Zhang et al., 1999) and Mta3 (Simpson et al., 2001 ). In addition, in pancreatic acinar cells, a derivative of the rat mta1 gene, ZG29, has been identi®ed (Kleene et al., 1999) . MTA1 contains regions of homology with several immediate early genes (Herman et al., 1999; Paterno et al., 1997) encoding transcription factors involved in cell growth regulation. Recent studies demonstrate that MTA1 and MTA2 are members of the nucleosomemodeling complex with histone deacetylase activity consistent with a role of these proteins in transcriptional regulation Zhang et al., 1999) . MTA1 was originally identi®ed based on its overexpression in metastatic rat breast cancer (Toh et al., 1994 (Toh et al., , 1995 . However, little is known about functional aspects of MTA1 expression as they relate to either the normal or the transformed cellular phenotype.
Recently, it was shown that, in malignant breast epithelial cells, MTA1 expression is induced by activation of the heregulin/HER2 pathway (Mazumdar et al., 2001) . The HER2/c-erbB2 receptor is an orphan receptor tyrosine kinase. When expressed at physiological levels it requires heterodimerization with and transphosphorylation by other members of the epidermal growth factor receptor (EGFR) family for activation (Pinkas-Kramarski et al., 1998) . Deregulated EGFR activation frequently occurs in epithelial malignancies, including squamous and breast carcinomas (Barnard et al., 1994; Le Jeune et al., 1993; Mukaida et al., 1991; Ozawa et al., 1989) . Collectively, these earlier studies raised the question whether EGFR activation may contribute to MTA1 expression in epithelial cells, and, thus, may enhance their malignant potential.
In the present study we focused on functional aspects of MTA1 expression as they relate to the malignant phenotype of transformed human keratinocytes. We describe that MTA1 expression supported several cellular functions relevant to the metastatic phenotype including survival in the anchorage-independent state, migration, and invasion. In addition, we demonstrate that MTA1 expression in immortalized keratinocytes was induced by EGFR activation and was necessary for, but not sucient to EGFRdependent, matrix-independent survival of these cells.
These results highlight a previously unrecognized role of MTA1 in support of EGFR-dependent survival of epithelial cells in the anchorage-independent state.
Results

Mta1 expression in normal and immortalized epidermal keratinocytes
MTA1 was originally identi®ed in transformed rat mammary epithelial cells (Toh et al., 1994) . Subsequent studies demonstrated human MTA1 mRNA expression also in esophageal squamous cell carcinomas (Toh et al., 1999) . These results led us to investigate MTA1 expression patterns in a panel of normal, immortalized, and malignant keratinocyte lines. Immortalized HaCaT keratinocytes were included because they are very similar to normal keratinocytes (Boukamp et al., 1988) but are amenable to stable transfection providing us with the opportunity to manipulate MTA1 expression. To assess MTA1 protein expression, we generated a polyclonal antiserum to a peptide unique to MTA1. Immunohistochemical analysis of adult human epidermis with the anti-MTA1 antiserum ( Figure 1a , panel 2) but not the normal rabbit serum (Figure 1a , panel 1) demonstrated nuclear staining of normal keratinocytes in situ throughout the nucleated epidermis. In squamous cell carcinoma skin tissues tested, MTA1 staining was dramatically enhanced (representative example of three, Figure 1a , panels 3 and 4) compared to normal epidermis and appeared to be localized to the cytoplasm as well as the nucleus. Immunoblotting analysis of epidermal protein extracts revealed a prominent protein species of expected molecular mass (*73 kDa) reacting with the MTA1 antiserum ( Figure  1b) . To compare MTA1 expression in normal and malignant keratinocytes, we assessed steady-state MTA1 mRNA and protein levels in vitro. As determined by RT ± PCR, MTA1 transcripts were present in both cell types, albeit at considerably lower levels in normal keratinocytes relative to a panel of squamous carcinoma cell lines (Figure 2a ). MTA1 expression levels in HaCaT keratinocytes were intermediate, i.e. slightly higher than in primary keratinocytes yet consistently lower than in squamous carcinomas. Low to moderate expression of MTA1 in normal keratinocytes and HaCaT cells as compared to A431 squamous carcinoma cells was con®rmed by immunoblotting analysis using the MTA1 antiserum ( Figure 2b ).
MTA1 is not required for keratinocyte proliferation
To study functional aspects of MTA1 expression in keratinocytes, we established HaCaT cell variants that expressed MTA1 cDNA in both, the sense or antisense orientation using a tetracycline-regulatable expression system. To assess transgene expression HaCaT-Mock (vector alone), HaCaT-MTA1-S (sense), and HaCaT-MTA1-AS (antisense) expressing cells were grown for 2 days in the presence or absence of tetracycline followed by Western blot analysis of MTA-1 expression. Under these conditions, HaCaT-MTA1-S cells expressed markedly higher MTA1 levels than mock-transfected cells whereas HaCaT-MTA1-AS cells expressed barely detectable MTA1 protein (Figure 3a) . Densitometric quantitation of the Western blot analyses of MTA1 expression relative to b-actin signal con®rmed the dierences in expression levels between the dierent transfectants ( Figure 3b) . Immunostaining con®rmed the results of the Western blot analysis (Figure 3c ). Note that transgene expression was leaky as MTA expression was slightly diminished in MTA1-AS expressing cells and moderately elevated in MTA1-S expressing cells even in the presence of tetracycline. Thus, MTA1 expression in the MTA1-S-transfected cells in the uninduced state was consistently higher than in mock-transfected cells but reproducibly lower than that of induced MTA1-Stransfected cells.
To determine eects of MTA1 expression on cellular metabolism, HaCaT-Mock, HaCaT-MTA-S, and HaCaT-MTA-AS cells were grown for 24, 48 or 72 h in the presence or absence of FCS without tetracycline to induce transgene expression and then treated with Alamar Blue TM . As determined by this assay overexpression of either sense or antisense MTA1 sequences had no signi®cant eect on cellular metabolism (data not shown). Furthermore, cellular proliferation was unaected as determined by counting cells at various time points after transgene induction (data not shown). Similarly, expression of sense and antisense MTA1 sequences did not detectably aect cell cycle distribution as assessed by FACS analysis of propidium iodide stained cells (data not shown). In summary, MTA1 expression did not aect cellular metabolism, cell numbers, or cell cycle distribution within 3 days after transgene induction.
MTA1 supports keratinocyte migration and invasiveness in vitro
Next, we determined whether MTA1 expression aected keratinocyte migration using an in vitro wound-healing assay (Figure 4a ). Migration was assessed by scratching a con¯uent monolayer of cells and monitoring closure of the defect over time. Relative to mock-transfected cells MTA1 overexpressing HaCaT cells demonstrated markedly enhanced migratory behavior whereas MTA1 antisense expressing cells did not migrate at all. Migration was expressed as distance from the wound edge measured 48 h after wounding (Figure 4b ). MTA1 overexpression in HaCaT-MTA1-S cells was associated with a signi®cant increase (P40.05; Student's t-test for unpaired samples) in migratory potential relative to mock-transfected control cells. To assess the contribution of MTA1 to invasion of HaCaT cells, we performed standard Boyden chamber assays using Biocoat 1 Matrigel 1 coated membranes and fetal bovine serum as a chemoattractant (Figure 4c ).
Invasiveness was expressed as the number of cells migrating through Matrigel 1 relative to migration through uncoated control inserts. MTA1 overexpression in HaCaT-MTA1-S cells was associated with a signi®cant increase (P40.05; Student's t-test for unpaired samples) in invasive potential as compared to mock-transfected cells. Because HaCaT cells were not normally invasive, abolishing MTA1 expression did not alter their invasive behavior.
MTA1 protects keratinocytes from anoikis
It is believed that invasion and metastatic dissemination of epithelial cells is limited by the inability of normal cells to survive in the absence of appropriate extracellular matrix. In support of this notion, immortalized (Frisch and Francis, 1994; Rodeck et al., 1997) and normal cultured keratinocytes undergo apoptosis when denied attachment to extracellular (Frisch and Francis, 1994; Rosen et al., 2000) . Furthermore, EGFR activation by exogenous or endogenous ligands provides partial protection against death to HaCaT cells in suspension (Jost et al., 2001b) . Based on these considerations we asked whether MTA1 expression aected survival of HaCaT cells in the anchorage independent state. To this end, we placed HaCaT cells expressing sense and antisense MTA1 in forced suspension culture for 24 ± 72 h followed by transfer to tissue culture-treated plastic and assessment of clonogenic growth 7 days after reseeding. The results of a representative experiment using growth factor-free medium during suspension culture are shown in Figure  5a . In this setting, survival of mock-transfected and MTA1-sense expressing HaCaT cells was comparable. By contrast, expression of MTA antisense sequences markedly reduced the fraction of cells reattaching after 24, 48 and 72 h of suspension culture. As expected, EGFR blockade by use of the EGFR antagonistic antibody 425 reduced survival of mocktransfected HaCaT cells. Importantly, survival of HaCaT-MTA1-S cells was similarly diminished by EGFR blockade suggesting that MTA1 expression alone is not sucient to relieve the requirement for EGFRderived signals for cell survival in the anchorageindependent state. Consistent with earlier results (Jost et al., 2001a) addition of EGF to the culture medium during suspension culture markedly improved survival of HaCaT-MTA-S cells (Figure 5b ). However, overexpression of MTA1 antisense sequences obviated EGFdependent HaCaT cell survival in forced suspension culture indicating that MTA1 expression is essential to EGFR-dependent HaCaT cell survival in suspension culture. The concentrations of mAb 425 and EGF have been optimized for this assay as previously published (Jost et al., 2001a) . The dierences in clonogenic growth after suspension culture were not due to dierences in cellular proliferation in the suspended state because forced suspension of HaCaT cells induced cell cycle arrest as assessed by BrdU incorporation (DeHoratius and Rodeck, unpublished results).
Regulation of MTA1 expression through activation of the EGFR
Next, we determined whether expression of MTA1 was regulated through an EGFR-dependent pathway. To this end, we examined the eects of EGFR blockade on expression of MTA1 steady-state mRNA and protein levels in HaCaT cells. Two EGFR antagonists were used in these studies. Whereas the monoclonal EGFR antagonistic antibody 425 (mAb 425) blocks ligand binding and EGFR autophosphorylation, tyrphostin AG1478 (Levitzki and Gazit, 1995) selectively inhibits the tyrosine kinase moiety of the EGFR. Blocking the EGFR with either mAb 425 or AG1478 in attached cells for 2 days was associated with markedly downregulated MTA1 mRNA expression in HaCaT cells relative to expression of GAPDH (Figure 6a ). This result was con®rmed by Western blot analysis of MTA1 expression upon inhibition of EGFR signaling (Figure 6b ). Treatment of HaCaT cells with either EGFR selective AG1478 or EGFR speci®c mAb 425 was associated with lower levels of MTA1 expression relative to untreated controls or cells treated with control tyrphostin AG1295 or control mAb BR15-6A. Down-regulation of MTA1 expression was reversible as incubation with either EGF or FCS was able to rescue the eect of mAb 425 treatment (Figure 6c ).
MTA1-dependent regulation of Bcl-x L expression
Previously, we and others (Frisch and Francis, 1994; Rosen et al., 2000) described that expression of the anti-apoptotic Bcl-2 family member Bcl-x L is important for survival of normal epithelial cells including normal keratinocytes and HaCaT cells in forced suspension culture. As MTA1 expression provided a measure of protection to HaCaT cells in suspension, we determined whether inhibiting MTA1 expression aected Bcl-x L expression. We observed marked downregulation of Bcl-x L protein levels in HaCaT-MTA1-AS cells as compared to HaCaT-MTA1-S cells ( Figure 7 ). As our previous work implicated MEK/MAPK signals in regulation of Bcl-x L expression levels in HaCaT cells (Jost et al., 2001a) , we asked whether inhibition of MEK activity aected MTA1 expression. Neither pharmacological inhibition of MEK activity by PD98059 nor over- (Jost et al., 2001a; Mansour et al., 1994) in HaCaT cells aected MTA1 expression as determined by immunoblot analysis (not shown). This indicates that MEK activity was not involved in regulating MTA1 expression levels in HaCaT keratinocytes. We conclude that EGFR-dependent MTA-1 expression contributes to Bcl-x L expression in HaCaT keratinocytes.
Discussion
The results presented here highlight a previously unrecognized role of MTA1 in support of epithelial cell survival in the anchorage-independent state. Speci®cally, we describe that (1) MTA1 is expressed at comparatively low levels in normal and immortalized epidermal keratinocytes; (2) forced MTA1 expression enhances migration and invasion of immortalized keratinocytes; (3) forced MTA1 expression enhances survival of immortalized keratinocytes in forced suspension culture; (4) MTA1 expression in immortalized keratinocytes is controlled, in part, by the EGFR; (5) like the EGFR, MTA1 contributes to expression of the anti-apoptotic Bcl-2 family member Bcl-x L in keratinocytes and; (6) MTA1 acts in concert with other EGFR targets to achieve cell survival in the anchorage-independent state.
Our results con®rm and signi®cantly extend ®ndings published during preparation of this manuscript and relating to MTA1 expression in mammary epithelial cells (Mazumdar et al., 2001) . Speci®cally, forced expression of MTA1 in MCF7 mammary carcinoma cells was associated with enhanced invasion in Boyden chamber assays and increased colony formation in soft agar. Similarly, we observed enhanced migration and invasion of HaCaT keratinocytes overexpressing MTA1. Mazumdar et al. (2001) reported no eect of MTA1 overexpression on [ 3 H]-thymidine uptake of MCF7 cells. Similarly, in our hands, neither overexpression nor inhibition of MTA1 expression had any detectable eect on metabolic rates, cell cycle progression, or proliferation of HaCaT keratinocytes. This is in contrast to a previous report describing growth inhibition of human MDA-MB-231 breast cancer cells upon treatment with MTA1 antisense oligonucleotides (Nawa et al., 2000) . The reason for this discrepancy is unknown but might relate to dierences in cell type expression level of MTA1.
Here, we provide direct evidence that MTA1 expression is required for survival of immortalized keratinocytes in conditions of anchorage independence, i.e. in forced suspension culture. Taken together, the results by Mazumdar et al. (2001) and our ®ndings suggest that MTA1-dependent support of epithelial cell survival enhances the capacity of epithelial cells to successfully complete metastatic dissemination to distant sites. Mazumdar et al. (2001) reported upregulation of MTA1 expression in MCF7 breast cancer cells through a heregulin-mediated pathway; heregulin is a ligand for the EGFR-like receptors HER3 and HER4. Our results indicate that EGFR ligands serve a similar role in epithelial keratinocytes. Importantly, both the EGFR and HER3/HER4 activate the orphan receptor HER2. As HER2 is expressed in HaCaT keratinocytes (Ahmed et al., 1997) it is possible that EGFR activation upregulates MTA1 expression through a mechanism involving HER2 transphosphorylation. This possibility is presently under investigation.
Interestingly we observed that HaCaT cells transfected with MTA1-antisense sequences expressed markedly lower levels of Bcl-x L . We described previously that EGFR-dependent Bcl-x L expression is required for matrix-independent HaCaT cell survival (Jost et al., 2001b; Rodeck et al., 1997) . Furthermore, Bcl-x L expression in these cells is controlled, in part, by MEK/ MAPK signaling (Jost et al., 2001a) . Consistent with a role of MTA1 in EGFR-dependent Bcl-x L regulation we observed that inhibition of EGFR activation was associated with reduced MTA1 expression in HaCaT keratinocytes. However, MTA1 expression in these cells did not depend on MAPK phosphorylation as neither the MEK inhibitor PD98059 nor a dominant negative MEK construct downregulated MTA1 expression. These results suggest that EGFR-dependent MTA1 expression and MEK/MAPK signaling cooperatively support Bcl-x L expression in keratinocytes. It remains to be investigated whether regulation of Bcl-x L expression by MTA1 is due to its histone deacetylase activity (Zhang et al., 1999) .
A recent study demonstrated that, in melanoma cells selected for survival in suspension culture, resistance to anoikis cosegregates with the ability of these cells to invade across Matrigel barriers (Zhu et al., 2001) . It is possible that forced MTA1 expression similarly enhances both, resistance to anoikis and invasive capacity of HaCaT cells. However, we observed that overexpression of MTA1 in HaCaT cells did not provide an unequivocal survival advantage relative to mocktransfected cells when these cells were placed in forced suspension culture. Yet, MTA1 overexpression markedly increased invasion across Matrigel-coated membranes. Thus, it remains to be investigated whether MTA1-dependent increased invasiveness is linked to enhanced survival of HaCaT cells in transit or whether MTA1 enhances the invasive phenotype independently of its role in support of cell survival.
In summary, MTA1 expression appears to be an important component of EGFR-dependent keratinocyte survival in the anchorage-independent state.
Materials and methods
Chemicals and reagents
Puri®ed mouse EGF was from Collaborative Research (Bedford, MA, USA). Monoclonal anti-EGFR antibody (mAb425) binds speci®cally to EGFR and blocks the binding of both EGF and TGF-a to EGFR (Murthy et al., , 1990 Rodeck et al., 1987) . Control mAb BR15-6A (363-15-6A) binds to but does not inhibit the EGFR expressed on epithelial cells . Tyrphostin AG1478 (Levitzki and Gazit, 1995; Yoneda et al., 1991) and control AG1295 were purchased from Calbiochem (San Diego, CA, USA). DAPI and antibodies to bactin were from Sigma (St. Louis, MO, USA).
Total RNA preparation, reverse transcription, and semiquantitative PCR Total cellular RNA was extracted from cultured cells using the Qiagen RNeasy kit (Qiagen, Valencia, CA, USA) or Tri Reagent (Sigma) according to the manufacturer's protocols. RT ± PCR analyses were performed using the Titan kit (Roche Molecular Biochemical, Indianapolis, IN, USA) according to the manufacturer's protocol. Alternatively, cDNA was generated from total RNA using oligo(dT) primers and MMLV reverse transcriptase (Gibco-BRL) in a ®nal volume of 20 ml consisting of 1 mg total RNA, 2.5 mM oligo(dT) primers, 10 mM DTT, 0.5 mM dNTP, and 10 units of MMLV reverse transcriptase. Primers speci®c to human MTA1 were: forward; 5'-AGC TAC GAG CAG CAC AAC GGG GT-3'; and reverse, 5'-CAC GCT TGG TTT CCG AGG AT-3'. The PCR conditions were 948C (3 min) and 20 ± 30 cycles of 948C (1 min), 588C (1 min), and 728C (2 min). PCR products were electrophoresed on a 2% SeaKem agarose gel (FMC) and semiquantitative evaluation of MTA1 RNA expression levels was performed relative to expression of the house keeping genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or b-actin. The primers for GAPDH were: forward, 5'-ACA GTC CAT GCC ATC ACT GCC-3'; and reverse, 5'-GCC TGC TTC ACC ACC TTC TTG-3'. The primers for b-actin were: forward, 5'-GTG GGG CGC CCC AGG CAC CA-3'; and reverse, 5'-CTC CTT AAT GTC ACG CAC GAT TTC-3'. The expected PCR products were 290 bp for MTA1, 268 bp for GAPDH and 540 bp for b-actin.
Preparation of anti-MTA1 antiserum
Based on the rat (GenBank accession number U02522) and mouse (Simpson et al., 2001 ) cDNA sequences, we designed and synthesized the following peptide`N'-RLDGERPGPNR-NNMSPH-`C' (Genemed Synthesis, San Francisco, CA, USA). This peptide shares sequence homology with the human MTA1`N'-RLDGERPGPNRSNMSPH-`C' with the exception of the serine residue. This peptide does not share homology with other human MTA proteins, MTA1-L1 or MTA2. The peptide was conjugated to keyhole limpet hemocyanin and used to immunize male New Zealand rabbits and antisera were prepared by CoCalico Biologicals (Reamstown, PA, USA).
Cell lines and tissues
Freshly isolated primary keratinocytes and HaCaT cells were obtained from Dr PJ Jensen (University of Pennsylvania, Philadelphia, PA, USA) and Dr N Fusenig (DKFZ, Heidelberg, Germany), respectively. A431 and SCC lines (SCC4, SCC9, SCC12, and SCC40) were either obtained from the American Type Culture Collection (ATCC, Bethesda, MD, USA) or kindly provided by Dr J Rheinwald (Harvard Institutes of Medicine, Boston, MA, USA). Human neonatal foreskin keratinocyte cultures were initiated and propagated in an MCDB base medium (MCDB153, Sigma) containing 30 mM Ca 2+ supplemented with ethanolamine, phosphorylethanolamine, hydrocortisone, insulin, puri®ed EGF, and bovine pituitary extract, as previously described in detail (McNeill and Jensen, 1990) . HaCaT, A431, and SCC cells were grown in W489 medium consisting of four parts of MCDB153 and one part L15 media supplemented with 2% fetal bovine serum (Rodeck et al., 1991) . To inhibit EGFR activation, cells were treated for 2 ± 4 days with mAb 425 (10 mg/ml), control mAb BR15-6A (10 mg/ml), AG1478 (10 mM), or control AG1295 (10 mM) as previously described (Jost et al., 1999) .
Expression of MTA1 sense and antisense sequences in HaCaT keratinocytes
Expression of MTA1 full-length sense and antisense sequences was achieved using an episomally maintained tetracycline (Tc)-regulatable eukaryotic expression vector system based on the Escherichia coli Tn10 tetracycline operon (Gossen and Bujard, 1992; Jost et al., 1997) . The following primers, forward 5' -ATG GCC GCC AAC ATG TAC AGG-3' and reverse 5'-CTA GTC CTC GAT GAC GAT GG-3', were used to amplify, from human placenta cDNA (Clontech), a 2.2 kb fragment encoding for human MTA1. The PCR conditions were as follows: 948C for 2 min, followed by 35 cycles of 948C for 30 s, 588C for 1 min, and 728C for 2 min. The MTA1 cDNA was GAPDH expression was determined to account for dierences in RNA concentrations. (b) Down regulation of MTA1 expression by mAb 425 is reversible. Cells grown in de®ned medium were treated with FCS (2%) or EGF (50 ng/ml) in the presence or absence of mAb 425 (10 mg/ml). Total RNA was prepared and MTA1 and b-actin levels were determined by RT ± PCR. The signi®cant reduction in MTA1 by mAb 425 was rescued by treatments with either EGF or FCS. (c) MTA1 expression in the presence and absence of EGFR antagonists, mAb 425 and AG1478, as determined by Western blot analysis. Reduced levels of MTA1 protein were apparent in extracts of cultures treated with either mAb 425 or AG1478 whereas treatment with control mAb BR15-6A and control tyrphostin had no eect on MTA1 expression. All samples were normalized to b-actin RNA for equal loading (Jost et al., 1999) ). Cells were selected in medium containing neomycin (G418; 400 mg/ml), hygromycin (0.2 mg/ml), and tetracycline (2 mg/ml) for 3 weeks. Expression of MTA1 cDNA in the sense (HaCaT-MTA1-S) or antisense (Ha-MTA1-AS) orientation was induced by removal of tetracycline from the culture medium. Mock-transfected HaCaT cells (HaCaT-Mock) expressed an empty pCEPTetP vector .
Immunocytochemistry and Western blot analysis
To determine MTA1 expression, cells were washed in ice cold PBS and ®xed for 10 min with 50% acetone in methanol at 7208C. After nonspeci®c sites were blocked for 30 min with 1% BSA in PBS, cells were then incubated with anti-MTA1 (1 : 100) or anti-a-tubulin (1 : 1000; Sigma) antibodies for 1 h at room temperature or 48C overnight. After a 15 min wash with PBS, cells were incubated with Texas-Red-conjugated goat anti-rabbit (1 : 200) or FITCconjugated goat anti-mouse (1 : 200) antibodies for 1 h at room temperature. Samples were washed with PBS and, where indicated, treated with 100 ng/ml DAPI (Sigma) for DNA counterstaining.
To determine MTA1 expression in situ, skin sections (5 mm) from formalin-®xed and paran-embedded tissues were used. Sections were deparanized in 100% xylene (5 min; two times), 100% ethanol (5 min; two times), 95% ethanol (5 min; two times), 75% ethanol (2 min), 50% ethanol (2 min) and H 2 O (2 min). Antigen retrieval was performed by incubating sections in 0.3% H 2 O 2 for 30 min at room temperature followed by treatment with an antigen retrieval solution (TUF, Signet Labs, Dedham, MA, USA) for 20 min at 958C. Nonspeci®c binding sites were blocked with Biotin/Avidin Blocking Kit (Vector Labs, Burlingame, CA, USA) and with BSA (1%). Sections were then incubated with primary antibodies for 2 h at room temperature or overnight at 48C followed by incubation with biotinylated-goat anti rabbit antibodies (1 : 200; Vector Labs) for 1 h at room temperature. After washing in PBS for 10 min, sections were incubated in VectaStain ABC (Vector Labs) for 30 min at room temperature, washed in PBS for 10 min and then stained with stable DAB (approximately 1 ± 5 min; Vector Labs). Finally, sections were washed with H 2 O, counterstained for 1 min with Gill's #3 Hematoxylin (diluted 1 : 10 in H 2 O; Fisher Scienti®c, Pittsburgh, PA, USA), washed again with H 2 O, mounted in elvanol and examined by light microscopy.
For Western blot analysis, cultured cells were washed in ice cold PBS and scraped into lysis buer (62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, and protease inhibitor cocktail; Boehringer Mannheim). Cell lysates were vortexed for 30 s, incubated on ice for 30 min, and centrifuged at 12 000 g for 10 min at 48C. Supernatants were boiled for 10 min in Laemmli buer and resolved by 10% SDS ± PAGE. Western blot analysis was performed as described previously (Mahoney et al., 1998) . Antibodies were used at the following dilutions: rabbit anti-MTA1 antibody (1 : 200); goat antirabbit IgG-horse radish peroxidase (HRP) (1 : 2000; BioRad Labs, Hercules, CA, USA); monoclonal anti-b-actin antibodies (1 : 1000; Calbiochem), and goat anti-mouse IgM-HRP (1 : 1000; Calbiochem).
Cell invasion assay
Biocoat
1 Matrigel 1 Invasion chambers (Becton Dickinson Labware, Bedford, MA, USA) were used following a protocol established previously for SCC cells (Kawahara et al., 1995) . The assay was carried out using 8 mm tissue culture inserts (Falcon-Fisher Scienti®c) coated with 90 mg of Matrigel (Becton Dickinson Labware) suspension in PBS per cm 2 . Control samples were plated onto uncoated inserts. Brie¯y, HaCaT-MTA1-S and HaCaT-MTA1-AS cells were grown to 50% con¯uency in the presence of tetracycline which was then removed from the medium for 2 days to induce transgene expression. The cells were then plated in the upper chambers using serum free medium at 5610 4 cells/ chamber while 10% FBS containing medium was added to the medium in the lower chambers. After incubation for 24 h at 378C in 95% air/5% CO 2 , the non-invading cells in the top chamber were removed. The membranes were ®xed with DiQuick kit (Dade Behring, Deer®eld, IL, USA), and cells which had traversed the side facing the lower chamber were counted using an inverted light microscope (30 optical ®elds; 2.562.5 mm grid). Each experimental condition was done in triplicate.
Cell proliferation and viability assays
To assess cell viability and cell proliferation, cells (5610   4   ) were grown in 96-well¯at-bottom culture dishes in the presence or absence of FCS for 24, 48 or 72 h. Cells were then incubated with 10% Alamar Blue TM (BioSource) in medium for 2 h. The Alamar Blue TM assay provides a measure of the oxidative metabolism of cells. Speci®cally, the active metabolism of proliferating cells favors a more reduced state as compared to non-proliferating cells. Thus, upon internalization into metabolically active cells the AlamarBlue TM dye shifts in color from the oxidized indigo blue, non-¯uorescing state to the reduced¯uorescent pink state. The redox state of Alamar Blue TM was measured spectrophotometrically by monitoring the absorption of Alamar Blue TM at two wavelengths, 530 and 590 nm, in a microtiter plate reader.
In addition, we used FACS analysis to assess cell viability and cell cycle distribution. Cells were trypsinized, washed once with PBS, and ®xed with 70% ethanol (7208C) for 2 h. After a brief wash with PBS, cells were treated with RNAse (1 mg/ml in PBS; Roche Molecular Biochemicals) for 5 min at 378C and stained with propidium iodide (5 mg/ml in PBS; Molecular Probes) for 20 min at 48C. Propidium iodide content of cells was analysed with a FACSort cyto¯uoro-graph (Becton Dickinson, San JoseÂ , CA, USA) and Lysis II Software (Becton Dickinson). A minimum of 10 5 cells was accrued for each experimental condition. Furthermore, cellular proliferation was also assessed by determining cell numbers using a hemocytometer.
Forced suspension culture
Forced suspension cultures were performed as described previously (Jost et al., 2001a) . Cells were suspended in growth factor-free MCDB base medium containing 0.2% fatty-acidfree bovine serum albumin (Boehringer Mannheim) and seeded at 4610 5 cells/well in 6-well culture dishes coated with 0.9% agarose gels prepared in the same medium. In select experiments, the base medium was supplemented with EGF (10 ng/ml; Sigma). After 48 ± 72 h, cell aliquots (4610 5 cells) were reseeded into 12-well culture dishes in W489 medium supplemented with 2% FCS and containing neomycin, hygromycin, and tetracycline. To assess survival and clonogenic capacity, reattached cells were ®xed with 70% ethanol 7 days after reseeding and stained with crystal violet. Abbreviations EGFR, epidermal growth factor receptor; MTA1, metastasis-associated protein 1.
